Mednet Logo
CommunityMedical Oncology

When do you start ADT for a patient with a new diagnosis of node positive prostate cancer receiving radiation?

Do you start neoadjuvantly? Concurrently?
Community PollStarted

When do you start ADT for node positive prostate cancer receiving RT?

405 physicians have voted

Join Mednetto vote and see how they answered.

5 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · UC San Diego
Answered on

I would reverse the question order. For node-positive disease, I start ADT once staging imaging is complete. If logistically practical (as with high-risk localized), I often perform the simulation and start ADT at the same time, then start RT without a neoadjuvant period. Evidence for neoadjuvant AD...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on · Updated on

We usually start upfront and start RT in a few months. This helps to see nodal response, can also sometimes help meet small bowel constraints with regression, and can also adjust the total dose if needed.

ASTRO 2022: Predictive Value of Ga68-PSMA PETCT-Based Response to Neoadjuvant Androgen Deprivat...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on

8 weeks prior to treatment planning

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Quillen VA Medical Center
Answered on

I have spent the last 25 years with a consistent philosophy about nodes and ADT. My basis: nodes are signposts of systemic disease that have yet to manifest. ADT is not curative but very effective at lowering PSA.

Now that we have Pylarify, we have a tool that should identify disease rather than ris...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Princess Margaret Hospital at University of Toronto
Answered on

My routine practice is to give ADT for at least 2-3 months prior to WPRT in patients with gross nodal disease with up to 3 years adjuvant therapy, and consideration of ARPI. It is demonstrated that 3-6 months ADT reduced nodal volume and that volume response is associated with improved disease contr...

Join for free or sign in to see the full answer